Physician
Hematology
Dr. Markus F. Renschler, MD
|
|
Give Review
Markus F. Renschler is an expert in the field of Hematology. He went to medical school at Stanford University School of Medicine. Stanford University School of Medicine is one of the top medical schools in the US. Stanford University School of Medicine is ranked 2/25 in Research/PrimaryCare. Markus Renschler is a published physician. He published 26 publications, including: 'Identification of peptide ligands for the antigen binding receptor expressed on human B-cell lymphomas.'
Publications
- Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer.
- Phase I study to assess the pharmacokinetics and the effect on cardiac repolarization of amrubicin and amrubicinol in patients with advanced solid tumors.
- Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-base...
- Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer.
- Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases...
- Population pharmacokinetics of motexafin gadolinium in adults with brain metastases or glioblastoma multiforme.
- Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase II...
- Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.
- Neurocognitive and functional assessment of patients with brain metastases: a pilot study.
- Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance im...
- Phases IB and II multidose trial of gadolinium texaphyrin, a radiation sensitizer detectable at MR imaging: preliminary results in brain metastases.
- Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases.
- Photoangioplasty for human peripheral atherosclerosis: results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin).
- In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancer.
- A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging.
- Identification of peptide ligands for the antigen binding receptor expressed on human B-cell Lymphomas.
- Overcoming the limitations of chemotherapy in the treatment of B-cell non-Hodgkin's Lymphomas--an approach using radiolabeled peptide ligands.
- Synthetic peptide ligands of the antigen binding receptor induce programmed cell death in a human B-cell Lymphoma.
- B-Lymphoma cells are activated by peptide ligands of the antigen binding receptor or by anti-idiotypic antibody to induce extracellular acidification.
- Avoiding exposure to HIV by needle stick.
- Avoiding needle-stick injuries in the emergency department.
- Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis.
- Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function.
- Comments about the prospective randomized trial by Aoyama et al.
- The emerging role of reactive oxygen species in cancer therapy.
Schools
Stanford University School Of Medicine
Conditions Treated
- Non-Hodgkin's Lymphoma
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Select PPO
- Access Plus Savenet
- Basic Exclusive PPO for Small Business
- Basic PPO
- Cigna HMO
- First Health (Coventry Health Care) PPO
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
Education
-
Stanford University -
Stanford University School of Medicine
Hospital
-
Stanford Health Care
Helpful Reviews
Similar Doctors
|
|
Dr. Branimir I. Sikic, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Rondeep S. Brar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence L. Leung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter L. Greenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric W. Humke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Klaus J. Porzig, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James L. Zehnder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sunil A. Reddy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven E. Artandi, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. David M. Nguyen, MD |